Skip to content

Assessing Early Behavioral Indicators of Formula Tolerance

Assessing Early Behavioral Indicators of Formula Tolerance

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02340143
Enrollment
71
Registered
2015-01-16
Start date
2015-01-31
Completion date
2016-08-31
Last updated
2016-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tolerance

Brief summary

The study is intended to assess the amount of crying and fussiness in infants fed an infant formula containing probiotics.

Interventions

OTHERControl

Marketed partially hydrolyzed cow's milk protein infant formula

Partially hydrolyzed cow's milk protein infant formula with a probiotic

Sponsors

Baylor College of Medicine
CollaboratorOTHER
Mead Johnson Nutrition
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
14 Days to 28 Days
Healthy volunteers
Yes

Inclusion criteria

* Singleton at birth * Term infant with birth weight of 2500 g or more * Crying or fussing for 3 or more hours per day * Consuming mostly infant formula * Signed Informed Consent and Protected Health Information authorization

Exclusion criteria

* Current use of extensively hydrolyzed or amino acid infant formula * Planned use of probiotics during the study * History of underlying metabolic or chronic disease, congenital malformation, or immunocompromised * Enrollment in another interventional clinical research study

Design outcomes

Primary

MeasureTime frame
Infant Behavior Diary21 Days

Secondary

MeasureTime frame
Body WeightBaseline and Day 21
Infant Behavior Questionnaire - RevisedBaseline and Day 21
Recall of Tolerance QuestionnaireBaseline and Day 21
Fecal microbiome and Fecal calprotectinBaseline and Day 21
Medically-confirmed Adverse Events21 Days
Recall of formula intake at each visitBaseline, Day 10, and Day 18

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026